InflaRx N.V. (IFRX)

NASDAQ: IFRX · USD

$1.73

+0.07 (+4.2%)· Recorded snapshot

Market cap	254.9M
Revenue (ttm)	-11.5K
Net income (ttm)	-44.7M
EPS (ttm)	-$0.54
Shares out	147.4M
Volume	470,037
Beta	2.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -11.5K
Net income (ttm): -44.7M
EPS (ttm): -$0.54
Market cap: 254.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-38.5

P25 n/aP50 n/aP75 n/a

ROIC-21.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All IFRX indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

EUR

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001708688
Company name	InflaRx N.V.
Country	Germany
Country code	US
CUSIP number	N44821101
Earnings date	2026-11-03
Earnings time	bmo
Employees	65
Employees change	-9
Employees growth	-12.16%
Enterprise value	$74.8M
Exchange	NASDAQ
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
Industry	Biotechnology
IPO date	2017-11-08
Is primary listing	Yes
Is SPAC	No
ISIN number	NL0012661870
Last 10-K release date	2026-03-20
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$254.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$1.73
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	IFRX
Website	https://www.inflarx.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-31.5%
FCF / EV yield	-41.17%
FCF yield	-10.85%
P/B ratio	1.46x
Price / tangible book value	1.47x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	352,966.34%
Pretax margin	387,411.93%
Profit per employee	$-688,021
ROA	-18.54%
ROA (5Y)	-31.59%
ROCE	-24.29%
ROE	-38.52%
ROE (5Y)	-53.96%
ROIC	-21.78%
SBC / revenue	-23,647.24%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	1
Net income growth quarters	2
Net income growth years	1
Revenue growth	-82.31%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-151,359
Depreciation and amortization	$12,993
EBIT	$-40.7M
EBITDA	$-40.7M
EPS	$-0.54
FCF per share	$-0.18
Financing cash flow	$143.5M
Free cash flow	$-26.6M
Free cash flow minus SBC	$-29.2M
Gross profit	$-5.6M
Income taxes	$14,032
Investing cash flow	$33.7M
Net borrowing	$-344,282
Net cash flow	$152.6M
Net income	$-44.7M
Operating cash flow minus SBC	$-29.1M
Operating income	$-40.7M
Revenue	$-11,540
Stock-based compensation	$2.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.14
Book value per share	$1.13
Debt / equity	0.01
Interest coverage	-582.09
Long-term assets	$6.5M
Long-term liabilities	$1.3M
Net cash (debt)	$180.1M
Net cash / market cap	73.64%
Net cash growth	232.68%
Net debt / equity	-1.08
Piotroski F-Score	3
Property, plant and equipment	$1.2M
Shareholders' equity	$167M
Tangible book value	$166.9M
Tangible book value per share	$1.13
Total assets	$190.7M
Total cash	$181.1M
Total debt	$951,878
Total liabilities	$23.7M
WACC	18.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$184.2M
Current liabilities	$22.4M
Current ratio	8.22
Net working capital	$-14.8M
Quick ratio	7.95
Working capital	$166M
Working capital turnover	-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-31.84%
Dividend yield	0%
Shareholder yield	-31.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$1.87
1D price change	4.22%
1M price change	-9.26%
1M total return	-9.26%
1W price change	11.36%
1W total return	11.36%
1Y price change	3.31%
1Y return CAGR	3.32%
1Y total return	3.31%
20-day SMA	$1.57
200-day SMA	$1.63
3M price change	0.88%
3M total return	0.88%
3Y price change	-0.29%
3Y return CAGR	-0.1%
3Y total return	-0.29%
50-day SMA	$1.88
50-day SMA vs 200-day SMA	50over200
52-week high	$2.95
52-week high date	2026-05-07
52-week low	$0.80
52-week low date	2026-02-05
5Y price change	-40.03%
5Y return CAGR	-9.72%
5Y total return	-40.03%
6M price change	6.52%
6M total return	6.52%
All-time high	$53.10
All-time high date	2019-04-24
All-time low	$0.71
All-time low date	2025-05-28
Average true range (ATR)	$0.12
Average volume	743.4K
Beta (1Y)	4.37
Beta (2Y)	1.92
Beta (5Y)	2.61
Change from 52-week high	-41.34%
Change from 52-week low	116.68%
Change from all-time high	-96.77%
Change from all-time low	141.11%
Change from open	2.98%
Day's gap	1.2%
Dollar volume	$813,164
High price	$1.73
Low price	$1.67
Monthly RSI	49.7
Open price	$1.68
Position in 52-week range	100%
Premarket change	0.75%
Premarket close	$1.66
Premarket price	$1.67
Previous close	$1.66
Price vs 150-day SMA	-8.04%
Price vs 20-day SMA	9.44%
Price vs 200-day SMA	5.21%
Price vs 50-day SMA	-8.97%
Relative volume	0.63
RSI	53.45
Sharpe ratio	0.43
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0.4
Sortino ratio	0.83
Sortino ratio (3Y)	0.73
Sortino ratio (5Y)	0.75
Volume	470K
Weekly RSI	49.09
YTD price change	69.8%
YTD total return	69.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	98.1M
Float percentage	66.58%
Shares change (QoQ)	62.76%
Shares change (YoY)	31.84%
Shares held by insiders	2.95%
Shares held by institutions	40.02%
Shares outstanding	147.4M
Short % of shares	9.15%
Short ratio	24.8 days

Deeper analysis on IFRX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IFRX report

Is a complete IFRX research report available?

No complete published report is available for InflaRx N.V. (IFRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

InflaRx N.V. (IFRX)

Price

Financial snapshot

Fair-value bridge

Latest news · IFRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IFRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IFRX

Frequently asked questions